The neutrophil-platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Watt, David G ^a   Proctor, Michael J ^a   Park, James H ^a   Horgan, Paul G ^a   McMillan, Donald C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL PLATELET SCORE; OVERALL SURVIVAL; PREDICTION; PROSTATE CANCER; SCORING SYSTEM; SURVIVAL TIME; THROMBOCYTE COUNT; BLOOD; COLORECTAL NEOPLASMS; IMMUNOLOGY; INNATE IMMUNITY; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; NEUTROPHIL; PREDICTIVE VALUE; PROGNOSIS; THROMBOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNITY, INNATE; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NEUTROPHILS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84952684611     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142159     Document Type: Article

References (24)

1. CRUK. Available: http://wwwcancerresearchukorg/about-cancer/type/bowel-cancer/treatment/statistics-and-outlook-for-bowel-cancer. 2014.
2. Oliphant R, Nicholson GA, Horgan PG, Molloy RG, McMillan DC, Morrison DS. Contribution of surgical specialization to improved colorectal cancer survival. The British journal of surgery. 2013;100(10):1388-95. doi:10.1002/bjs.9227 PMID: 23939852
3. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future oncology (London, England). 2010;6(1):149-63.
4. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Critical reviews in oncology/hematology. 2013;88(1):218-30. doi:10.1016/j.critrevonc.2013.03.010 PMID: 23602134
5. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer treatment reviews. 2013;39(5):534-40. doi:10.1016/j.ctrv. 2012.08.003 PMID: 22995477
6. Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Journal of the National Cancer Institute. 2014;106(6):dju124. doi:10.1093/jnci/dju124 PMID: 24875653
7. Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. International journal of cancer Journal international du cancer. 2014;134(10):2403-13. doi:10.1002/ijc.28536 PMID: 24122750
8. Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Annals of surgery. 2015. PMID: 25575264
9. Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Annals of surgery. 2015. PMID: 25915915
10. Watt DG, Martin JC, Park JH, Horgan PG, McMillan DC. Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer. American journal of surgery. 2015;210(1):24-30. doi:10.1016/j.amjsurg.2014.12.031 PMID: 25842358
11. Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, et al. Neutrophils scan for activated platelets to initiate inflammation. Science. 2014;346(6214):1234-8. doi:10.1126/science. 1256478 PMID: 25477463
12. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. British journal of cancer. 2013;109(2):401-7. doi:10.1038/bjc.2013.350 PMID: 23820256
13. Ishizuka M, Oyama Y, Abe A, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. Journal of surgical oncology. 2014;110(8):935-41. doi:10.1002/jso.23753 PMID: 25146385
14. Feng JF, Huang Y, Chen QX. The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Translational oncology. 2014;7(5):632-7. doi:10.1016/j.tranon. 2014.07.009 PMID: 25389458
15. Kumar R, Geuna E, Michalarea V, Guardascione M, Naumann U, Lorente D, et al. The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. British journal of cancer. 2015;112(7):1157-65. doi:10.1038/bjc.2015.67 PMID: 25719834
16. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. British journal of cancer. 2007;97(9):1266-70. PMID: 17923866
17. Proctor MJ, McMillan DC, Horgan PG, Fletcher CD, Talwar D, Morrison DS. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study. PloS one. 2015;10(3):e0116206. doi: 10.1371/journal.pone.0116206 PMID: 25730322
18. Proctor MJ, Talwar D, Balmar SM, O'Reilly DS, Foulis AK, Horgan PG, et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. British journal of cancer. 2010;103(6):870-6. doi:10.1038/sj.bjc.6605855 PMID: 20717110
19. Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer. 2013;119(12):2325-32. doi:10.1002/cncr.28018 PMID: 23575969
20. Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(51):20262-7. PMID: 18077379
21. Ten Kate M, Aalbers AG, Sluiter W, Hofland LJ, Sonneveld P, Jeekel J, et al. Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium. Anticancer research. 2007;27(1 A):17-22. PMID: 17352210
22. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine reviews. 1997;18(1):4-25. PMID: 9034784
23. Segal AW. How neutrophils kill microbes. Annual review of immunology. 2005;23:197-223. PMID: 15771570
24. Jain S, Harris J, Ware J. Platelets: linking hemostasis and cancer. Arteriosclerosis, thrombosis, and vascular biology. 2010;30(12):2362-7. doi:10.1161/ATVBAHA.110.207514 PMID: 21071699